Add to a list

Inactive Instrument

Carmat Share Price Other OTC

FR0010907956

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Analysts' recommendations: Carmat

09/25/09	Carmat: Invest Securities raises target price
11/25/11	Carmat: Invest Securities still a buyer, but cuts TP
04/25/04	Carmat: Invest Securities slightly lowers its target
09/25/09	Carmat: Invest Securities upgrades to buy
09/25/09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat

04/03	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
07/01	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
07/01	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
07/01	CARMAT : A suivre aujourd'hui
07/01	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	61.46L 69.17L 57.36L 52.28L 98.6L 66Cr 99.52L 6.94Cr 2.69Cr 34Cr 2.6Cr 2.54Cr 109.1Cr	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	5.92Cr 6.67Cr 5.53Cr 5.04Cr 9.51Cr 641.02Cr 9.59Cr 67Cr 26Cr 327.7Cr 25Cr 24Cr 1.05TCr	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

01/09	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
07/01	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
07/01	CARMAT: To Watch Today
06/01	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
06/01	Carmat Announces Liquidation and Delisting
02/12	Only Takeover Bid for Carmat Approved by Court
02/12	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
02/12	Carmat receives takeover bid	RE
04/11	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/25/15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/25/15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/25/15	Carmat says liquidation review postponed until Nov 25	RE
01/25/01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

02/12	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
04/11	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/25/29	CARMAT : Inside Information / Other news releases	PU
29/25/29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/25/15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT	-.--%	-.--%	-	-	70.8L
ABBOTT LABORATORIES	+0.84%	-3.74%	-27.56%	+1.79%	17TCr
MEDTRONIC PLC	-0.07%	-2.55%	-11.59%	+12.86%	11TCr
STRYKER CORPORATION	+0.90%	+1.13%	-25.66%	+3.60%	11TCr
ESSILORLUXOTTICA	-1.24%	-0.76%	-49.50%	-12.08%	7.39TCr
CENCORA, INC.	-0.24%	+0.69%	+2.08%	+71.44%	5.9TCr
HOYA CORPORATION	-0.86%	+2.96%	+12.91%	+61.58%	5.13TCr
BECTON, DICKINSON AND COMPANY	-0.71%	-3.82%	-8.68%	-31.71%	4.82TCr
IDEXX LABORATORIES, INC.	+0.12%	-0.17%	-17.87%	+21.91%	4.08TCr
DEXCOM, INC.	-1.01%	-1.45%	+27.31%	-6.14%	3.22TCr
Average	-0.23%	-0.86%	-10.95%	+13.69%	7.67TCr
Weighted average by Cap.	+0.03%	-1.30%	-17.07%	+11.23%

	2023	2024
Net sales	38.37L 43.19L 35.81L 32.64L 61.56L 42Cr 62.13L 4.33Cr 1.68Cr 21Cr 1.62Cr 1.59Cr 68Cr	73.44L 82.66L 68.54L 62.48L 1.18Cr 79Cr 1.19Cr 8.3Cr 3.21Cr 41Cr 3.1Cr 3.04Cr 130.37Cr
Net income	-5.39Cr -6.06Cr -5.03Cr -4.58Cr -8.64Cr -582.84Cr -8.72Cr -61Cr -24Cr -297.96Cr -23Cr -22Cr -956.26Cr	-5.14Cr -5.78Cr -4.8Cr -4.37Cr -8.25Cr -556.08Cr -8.32Cr -58Cr -22Cr -284.27Cr -22Cr -21Cr -912.34Cr
Net Debt	4.96Cr 5.59Cr 4.63Cr 4.22Cr 7.96Cr 537.05Cr 8.04Cr 56Cr 22Cr 274.54Cr 21Cr 21Cr 881.11Cr	5.31Cr 5.98Cr 4.96Cr 4.52Cr 8.52Cr 574.52Cr 8.6Cr 60Cr 23Cr 293.7Cr 22Cr 22Cr 942.6Cr

Carmat Share Price Other OTC

Stocks

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat

Latest news: Carmat

Analysts' recommendations: Carmat

Press Releases: Carmat

News in other languages: Carmat

Managers and Directors: Carmat

Medical Devices & Implants

Financials

Company Profile